| Controlled intermittent asystole cardiac therapy induced by pharmacologically potentiated vagus nerve stimulation in normal and hibernating myocardium. | |
| | |
MedLine Citation:
|
PMID: 12822638 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Pharmacologically potentiated electrical stimulation of the right vagus nerve achieves controlled intermittent asystole cardiac therapy. The present study examined pathophysiologic consequences of repetitive intermittent asystoles on contractile function, myocardial blood flow, and vagus nerve function and morphology. METHODS: Open-chest anesthetized canines, with either normal left anterior descending (LAD) coronary arteries (n = 8) or severely stenotic LADs (n = 8), received pharmacologic pretreatment with pyridostigmine (0.5 mg/kg), propranolol (80 microg/kg), and verapamil (50 microg/kg) before vagus nerve stimulation. Time-matched control animals with normal (n = 4) or severely stenotic LADs (n = 6) received drugs but no vagus nerve stimulation. The vagus nerve was stimulated for 12 seconds ("on") and rested for 15 seconds ("off"). This algorithm was repeated for 15 on-off cycles, simulating using controlled intermittent asystole during the placement of 15 sutures in a distal coronary anastomosis. This 15-cycle sequence was repeated twice more, simulating a three-vessel bypass. RESULTS: Normal coronary arteries: Ninety minutes after three sets of controlled intermittent asystole, LAD blood flow was unchanged from base line (36.6 +/- 4.5 versus 33.0 +/- 4.2 mL/min, p = 0.4), and global left ventricular performance (impedance catheter, end-systolic pressure-volume relations) was similar to baseline (7.4 +/- 1.2 versus 7.2 +/- 1.0 mm Hg/mL, p = 0.1). Left anterior descending coronary artery stenosis model: Ninety minutes after CIA, there were no significant differences versus control animals in regional LAD blood flow (27 +/- 4 versus 29 +/- 5 mL/min, p = 0.4) or fractional shortening of LAD myocardium (sonomicrometry; 6.2% +/- 1.8% versus 5.4% +/- 1.2%, p = 0.1). Vagus nerve conduction and morphology were unchanged from baseline. CONCLUSIONS: Repetitive controlled intermittent asystole does not impair poststimulation coronary blood flow, cardiac contractile function, or vagus nerve function. Controlled intermittent asystole may be useful to facilitate off-pump or endoscopic coronary artery bypass grafting. |
| | |
Authors:
|
Russell S Ronson; John D Puskas; Vinod H Thourani; Daniel A Velez; Bradley L Bufkin; Jonathan Glass; Robert A Guyton; Jakob Vinten-Johansen |
Related Documents
:
|
9486258 - Selective large coronary endothelial dysfunction in conscious dogs with chronic coronar... 3812268 - Metabolic and hemodynamic effects of nicardipine during pacing-induced angina pectoris. 3343858 - Elevated coronary sinus pressure does not alter myocardial blood flow or left ventricul... 18607168 - The association of elasticity indexes of ascending aorta and the presence and the sever... 893268 - Significance of sympathetic innervation of pulmonary vessels in response to acute hypoxia. 461068 - Individual difference in anticipatory physiological responses to signaled stress: role ... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: The Annals of thoracic surgery Volume: 75 ISSN: 0003-4975 ISO Abbreviation: Ann. Thorac. Surg. Publication Date: 2003 Jun |
Date Detail:
|
Created Date: 2003-06-25 Completed Date: 2003-07-23 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 15030100R Medline TA: Ann Thorac Surg Country: United States |
Other Details:
|
Languages: eng Pagination: 1929-36 Citation Subset: AIM; IM |
Affiliation:
|
Cardiothoracic Research Laboratory, Department of Surgery, Division of Cardiothoracic Surgery, Carlyle Fraser Heart Center of Crawford Long Hospital, Atlanta, Georgia 30308-2225, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Coronary Artery Bypass / methods Coronary Circulation / drug effects, physiology Coronary Stenosis / pathology, physiopathology Creatine Kinase / metabolism Dogs Drug Synergism Electric Stimulation Therapy / methods* Endoscopy Female Heart Arrest / pathology, physiopathology* Hemodynamics / drug effects, physiology Ischemic Preconditioning / methods* Male Models, Cardiovascular Myocardial Contraction / drug effects, physiology Myocardial Reperfusion Injury / pathology, physiopathology Myocardial Stunning / pathology, physiopathology* Peroxidase / metabolism Propranolol / pharmacology* Pyridostigmine Bromide / pharmacology* Vagus Nerve / drug effects, pathology, physiopathology* Verapamil / pharmacology* |
| Chemical | |
Reg. No./Substance:
|
101-26-8/Pyridostigmine Bromide; 52-53-9/Verapamil; 525-66-6/Propranolol; EC 1.11.1.7/Peroxidase; EC 2.7.3.2/Creatine Kinase |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Occupational exposure to inhalational anesthetics during cardiac surgery on cardiopulmonary bypass.
Next Document: Fetal myocardial protection is markedly improved by reduced cardioplegic calcium content.